Follow
Craig Martin
Title
Cited by
Cited by
Year
Pharmacology of systemic antifungal agents
ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes
Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006
4212006
Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus
SA Grim, RP Rapp, CA Martin, ME Evans
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (2 …, 2005
1272005
Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime
WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess
Antimicrobial agents and chemotherapy, AAC. 02089-16, 2016
1082016
Rhabdomyolysis during therapy with daptomycin
S Papadopoulos, AM Ball, SE Liewer, CA Martin, PS Winstead, ...
Clinical Infectious Diseases 42 (12), e108-e110, 2006
922006
Results of an antimicrobial control program at a university hospital
C Martin, I Ofotokun, R Rapp, K Empey, J Armitstead, C Pomeroy, ...
American Journal of Health-System Pharmacy 62 (7), 732-738, 2005
822005
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness
AK Gross, SP Dunn, DJ Feola, CA Martin, R Charnigo, Z Li, A Abdel-Latif, ...
Journal of thrombosis and thrombolysis 35 (2), 147-154, 2013
732013
Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing
CA Martin, AD Hoven, AM Cook
European Journal of Clinical Microbiology & Infectious Diseases 27 (8), 635-642, 2008
662008
Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome
CA Martin, S Roberts, RN Greenberg
Clinical Infectious Diseases 35 (7), e78-e81, 2002
632002
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance
JM Rybak, K Marx, CA Martin
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (11 …, 2014
562014
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults
AM Cook, C Martin, VR Adams, RS Morehead
Antimicrobial agents and chemotherapy 55 (7), 3240-3243, 2011
472011
Nephrotoxicity in patients with or without cystic fibrosis treated with polymyxin B compared to colistin
RL Crass, WC Rutter, DR Burgess, CA Martin, DS Burgess
Antimicrobial agents and chemotherapy 61 (4), e02329-16, 2017
412017
Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole
D Hayes Jr, AM Ball, HM Mansour, CA Martin, JD Flynn
Exp Clin Transplant 9 (6), 399-404, 2011
232011
Fulminant invasive pulmonary aspergillosis after a near-drowning accident in an immunocompetent patient
KL Ratermann, BJ Ereshefsky, EL Fleishaker, AC Thornton, KP Buch, ...
Annals of pharmacotherapy 48 (9), 1225-1229, 2014
192014
Utilizing Monte Carlo Simulations to optimize institutional empiric antipseudomonal therapy
SJ Tennant, DR Burgess, JM Rybak, CA Martin, DS Burgess
Antibiotics 4 (4), 643-652, 2015
162015
Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients
RZ Thompson, CA Martin, DR Burgess, WC Rutter, DS Burgess
Journal of Cystic Fibrosis 15 (5), 660-663, 2016
142016
Benefits of a 24-hour inhouse on-call program for pharmacy residents
KW Mcconeghy, PS Winstead, AM Cook, CA Martin, KA Weant, JD Flynn
American Journal of Health-System Pharmacy 69 (24), 2160-2164, 2012
102012
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli
BJ Ereshefsky, MN Al-Hasan, Y Gokun, CA Martin
Journal of Chemotherapy 29 (1), 30-37, 2017
62017
Effect of Clopidogrel Treatment on the Incidence and Severity of Community Acquired Pneumonia: Results of a Five-Year Cohort Study
AK Gross, SP Dunn, DJ Feola, CA Martin, SS Smyth
Circulation 122 (Suppl 21), A19964-A19964, 2010
12010
Syphilis: Here Today...Gone Tomorrow?
C Martin
Pharmacotherapy Casebook, 11th ed., 2019
2019
Erratum for Rutter et al., Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime
WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess
Antimicrobial agents and chemotherapy 61 (4), 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20